StimuSIL, Inc. — Form D/A

StimuSIL, Inc. of WILMINGTON, DE, a company, filed a Form D amendment with the SEC on 2022-08-30. The offering totals $575K, of which $575K was reported sold. Industry: Biotechnology.

Offering

Filed: 2022-08-30
Form: D/A
Accession: 0001939123-22-000002
Industry: Biotechnology
Exemptions: 06b
Total offering: $575K
Amount sold: $575K
Investors: 12
Date of first sale: 2022-07-01
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-455853

Issuer

Name: StimuSIL, Inc.
CIK: 0001939123
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2021
Address: 2810 Church Street, PMB 78535, WILMINGTON, DE, 19802
Phone: +49 (176) 3011 2000

Officers, directors & promoters (6)

Name	Role	Location
Abidin Gulmus	Director	Wilmington, DE
Ana Villalba Villar	Director	Wilmington, DE
Ana Villalba Villar	Executive Officer	Wilmington, DE
Pablo Villalba	Director	Wilmington, DE
Pablo Villalba	Executive Officer	Wilmington, DE
Firat Yerlikaya	Director	Wilmington, DE

Other filings by this issuer (4)

Filed	Form	Offering	Sold
2025-03-07	D	$600K	$600K
2024-05-10	D	$1.1M	$1.1M
2023-09-13	D	$49K	$49K
2022-08-12	D	$570K	$570K

More